{"organizations": [], "uuid": "776257b8b3ee5dc45d02aff49170f51870799537", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-fennec-pharmaceuticals-receives-fa/brief-fennec-pharmaceuticals-receives-fast-track-designation-by-fda-for-pedmark-idUSASC09T46", "country": "US", "domain_rank": 408, "title": "BRIEF-Fennec Pharmaceuticals Receives Fast Track Designation By FDA For Pedmark", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-03-21T12:59:00.000+02:00", "replies_count": 0, "uuid": "776257b8b3ee5dc45d02aff49170f51870799537"}, "author": "", "url": "https://www.reuters.com/article/brief-fennec-pharmaceuticals-receives-fa/brief-fennec-pharmaceuticals-receives-fast-track-designation-by-fda-for-pedmark-idUSASC09T46", "ord_in_thread": 0, "title": "BRIEF-Fennec Pharmaceuticals Receives Fast Track Designation By FDA For Pedmark", "locations": [], "entities": {"persons": [], "locations": [{"name": "u.s.", "sentiment": "none"}], "organizations": [{"name": "fda", "sentiment": "negative"}, {"name": "fda for pedmark reuters", "sentiment": "none"}, {"name": "reuters) - fennec pharmaceuticals inc", "sentiment": "none"}, {"name": "fennec pharmaceuticals", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 21, 2018 / 11:01 AM / in 15 minutes BRIEF-Fennec Pharmaceuticals Receives Fast Track Designation By FDA For Pedmark Reuters Staff March 21 (Reuters) - Fennec Pharmaceuticals Inc: * FENNEC PHARMACEUTICALS RECEIVES FAST TRACK DESIGNATION BY FDA FOR PEDMARK * FENNEC PHARMACEUTICALS- U.S. FDA GRANTED PEDMARK FAST TRACK DESIGNATION FOR PREVENTION OF CISPLATIN-RELATED OTOTOXICITY IN PEDIATRIC PATIENTS WITH SR-HB Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-03-21T12:59:00.000+02:00", "crawled": "2018-03-21T13:21:51.013+02:00", "highlightTitle": ""}